Jan Törnell
Board member
Medical Science
NeuroVive
Sweden
Biography
Born: 1960 Education: Doctoral degree and doctorate in physiology, University of Gothenburg Other ongoing missions: Chief Editor of Drug Discovery Today -Disease Models, published by Elsevier publisher and adjunct professor at the Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg. Jan is also chairman of LIDDS AB, Glactone Pharma AB and Glactone Pharma Development AB, as well as board member of Stayble AB and Diaprost AB, CEO of Oncorena AB and Innoext AB and partner in PULS AB. Shareholding in NeuroVive: -. Other: Independent in relation to the Company, the company management and the company's major shareholders.
Research Interest
His research interests lie in Healthcare and Medical Sciences. He is the Editor-in-Chief Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his authorship of many books.
